Cleared Traditional

K231174 - BPBIO750

K231174 is an FDA 510(k) clearance for BPBIO750, manufactured by Inbody Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 99-day FDA review.

K231174 · Inbody Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2023
Decision
99d
Days
Class 2
Risk

K231174 is an FDA 510(k) clearance for the BPBIO750. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Inbody Co., Ltd. (Cheonan-Si, KR). The FDA issued a Cleared decision on August 2, 2023 after a review of 99 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Inbody Co., Ltd. devices

FDA 510(k) Submission Details - K231174

510(k) Number K231174 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 25, 2023
Decision Date August 02, 2023
Days to Decision 99 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d faster than avg
Panel avg: 125d · This submission: 99d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Kamm & Associates
Daniel Kamm

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 565
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K231174.
Wrist Type Blood Pressure Monitor (W05,W1101L)
K230409 · Shenzhen Jamr Technology Co., Ltd. · Aug 2023
Arm-type Fully Automatic Digital Blood Pressure Monitor, Wrist-type Fully Automatic Digital Blood Pressure Monitor
K230566 · Joytech Healthcare Co. , Ltd. · Aug 2023
Electronic Blood Pressure Monitor
K230642 · Dongguan Kangweile Electronic Technology Co., Ltd. · Aug 2023
Arm Blood Pressure Monitor, models AOJ-33A and AOJ-33B
K222994 · Shenzhen AOJ Medical Technology Co., Ltd. · Jul 2023
Blood Pressure Monitor
K223374 · Guangdong Transtek Medical Electronics Co., Ltd. · Jun 2023
Upper Arm Blood Pressure Monitor
K230176 · Shenzhen Yolanda Technology Co., Ltd. · Jun 2023